Saroja Pharma Industries India (NSE:SAROJA) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SAROJA Saroja Pharma Industries India Ltd NSE:SAROJA
15 GF Score
Price ₹40.95
! 4 Warning Signs
View Full Analysis

What is Saroja Pharma Industries India FFO?

FFO (Funds from operations) only applies to REITs.

NSE:SAROJA
15GF Score
Saroja Pharma Industries India Ltd NSE:SAROJA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saroja Pharma Industries India Business Description

Address Jata Shankar Dosa Marg, Shop No. 209, 2ND Floor, Ecstacy, City of Joy, Mulund west, Mumbai, MH, IND, 400080
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
15GF Score

Get the complete analysis for NSE:SAROJA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.95
Price